Crossmark

Bone marrow derived mesenchymal stem cells ameliorate inflammatory response in an in vitro model of familial hemophagocytic lymphohistiocytosis 2

Crossref DOI link: https://doi.org/10.1186/s13287-018-0941-y

Published Online: 2018-07-18

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sevim, Handan https://orcid.org/0000-0002-8511-5258
Kocaefe, Yusuf Çetin

Onur, Mehmet Ali

Uçkan-Çetinkaya, Duygu

Gürpınar, Özer Aylin
Funding

Funding for this research was provided by:

Türkiye Bilimsel ve Teknolojik Araştirma Kurumu (TR) (SBAG-114S057)

Hacettepe Üniversitesi (013D12601001)
License Information

Text and Data Mining valid from 2018-07-18
More Information

Article History

Received: 12 April 2018

Revised: 31 May 2018

Accepted: 25 June 2018

First Online: 18 July 2018

Ethics approval and consent to participate

: This study was approved by Hacettepe University Local Ethical Committee (#LUT12/134-16). Written informed consent had been obtained from all human subjects who donated their bone marrow-derived mesenchymal stem cells which also included a consent for publication of the anonymized data.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.